We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+1.56%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$31.3B
AUM Growth
+$1.67B
Cap. Flow
+$1.83B
Cap. Flow %
5.84%
Top 10 Hldgs %
37.77%
Holding
1,441
New
112
Increased
695
Reduced
355
Closed
81

Top Buys

Rank Stock Value
1
PLTR icon
Palantir
PLTR
+$698M
2
NFLX icon
Netflix
NFLX
+$243M
3
VTR icon
Ventas
VTR
+$232M
4
META icon
Meta Platforms (Facebook)
META
+$184M
5
AMZN icon
Amazon
AMZN
+$153M

Sector Composition

Rank Sector Weight
1 Technology 30.75%
2 Real Estate 25.79%
3 Communication Services 11.7%
4 Consumer Discretionary 7.26%
5 Financials 6.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TECX
1326
Tectonic Therapeutic
TECX
$562M
$2K ﹤0.01%
80
ALLO icon
1327
Allogene Therapeutics
ALLO
$573M
$1K ﹤0.01%
535
ALT icon
1328
Altimmune
ALT
$581M
$1K ﹤0.01%
235
ARCT icon
1329
Arcturus Therapeutics
ARCT
$163M
$1K ﹤0.01%
90
AURA icon
1330
Aura Biosciences
AURA
$729M
$1K ﹤0.01%
165
AUTL
1331
Autolus Therapeutics
AUTL
$386M
$1K ﹤0.01%
575
AVIR icon
1332
Atea Pharmaceuticals
AVIR
$361M
$1K ﹤0.01%
242
AVXL icon
1333
Anavex Life Sciences
AVXL
$238M
$1K ﹤0.01%
314
BCYC
1334
Bicycle Therapeutics
BCYC
$275M
$1K ﹤0.01%
103
DSGN icon
1335
Design Therapeutics
DSGN
$741M
$1K ﹤0.01%
100
EDIT icon
1336
Editas Medicine
EDIT
$402M
$1K ﹤0.01%
277
IEUR icon
1337
iShares Core MSCI Europe ETF
IEUR
$8.82B
$1K ﹤0.01%
18
NBP
1338
NovaBridge Biosciences American Depositary Shares
NBP
$202M
$1K ﹤0.01%
+346
New +$1.53K
KMDA icon
1339
Kamada
KMDA
$407M
$1K ﹤0.01%
+192
New +$1.33K
LYEL icon
1340
Lyell Immunopharma
LYEL
$318M
$1K ﹤0.01%
45
NMRA icon
1341
Neumora Therapeutics
NMRA
$311M
$1K ﹤0.01%
533
OABI icon
1342
OmniAb
OABI
$286M
$1K ﹤0.01%
475
PAHC icon
1343
Phibro Animal Health
PAHC
$1.48B
$1K ﹤0.01%
38
PRME icon
1344
Prime Medicine
PRME
$558M
$1K ﹤0.01%
398
RCKT icon
1345
Rocket Pharmaceuticals
RCKT
$343M
$1K ﹤0.01%
304
SLDB icon
1346
Solid Biosciences
SLDB
$785M
$1K ﹤0.01%
231
-169
-42% -$916
TKNO icon
1347
Alpha Teknova
TKNO
$273M
$1K ﹤0.01%
300
VWO icon
1348
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$1K ﹤0.01%
21
VYGR icon
1349
Voyager Therapeutics
VYGR
$184M
$1K ﹤0.01%
201
LENZ
1350
LENZ Therapeutics
LENZ
$184M
$1K ﹤0.01%
91

Similar funds

Daiwa Securities Group's Q4 2025 Portfolio in Review

As of Q4 2025, Daiwa Securities Group held 1,441 positions worth $31.3B, up 5.6% from $29.6B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Daiwa Securities Group deployed $1.83B of net new capital in Q4 2025, opening 112 new positions and adding to 695 existing holdings. Its largest new stake was iShares Bitcoin Trust: 1,895,000 shares worth $94.1M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Real Estate and Communication Services.

On the sell side, the largest reduction was ServiceNow, an estimated $542M trimmed.

  • Daiwa Securities Group's largest Q4 2025 buy was iShares Bitcoin Trust: 1,895,000 shares worth $94.1M.
  • Daiwa Securities Group added most to Palantir in Q4 2025, an estimated $698M increase.
  • Daiwa Securities Group's biggest Q4 2025 reduction was ServiceNow, cutting an estimated $542M.
  • Daiwa Securities Group fully exited Eagle Materials in Q4 2025, selling an estimated $12.8M.
  • Daiwa Securities Group's ten largest holdings make up 38% of its $31.3B portfolio in Q4 2025.
  • Daiwa Securities Group opened 112 new positions and closed 81 in Q4 2025.
  • Daiwa Securities Group's portfolio value rose 5.6% quarter-over-quarter to $31.3B.

Based on Daiwa Securities Group's 13F filing for Q4 2025, filed 11 Feb 2026.